» Articles » PMID: 27625038

GluN2D-Containing N-methyl-d-Aspartate Receptors Mediate Synaptic Transmission in Hippocampal Interneurons and Regulate Interneuron Activity

Abstract

N-methyl-d-aspartate receptors (NMDARs) are ionotropic glutamatergic receptors that have been implicated in learning, development, and neuropathological conditions. They are typically composed of GluN1 and GluN2A-D subunits. Whereas a great deal is known about the role of GluN2A- and GluN2B-containing NMDARs, much less is known about GluN2D-containing NMDARs. Here we explore the subunit composition of synaptic NMDARs on hippocampal interneurons. GluN2D mRNA was detected by single-cell PCR and in situ hybridization in diverse interneuron subtypes in the CA1 region of the hippocampus. The GluN2D subunit was detectable by immunoblotting and immunohistochemistry in all subfields of the hippocampus in young and adult mice. In whole-cell patch-clamp recordings from acute hippocampal slices, (+)-CIQ, the active enantiomer of the positive allosteric modulator CIQ, significantly enhanced the amplitude of the NMDAR component of miniature excitatory postsynaptic currents (mEPSCs) in CA1 interneurons but not in pyramidal cells. (+)-CIQ had no effect in slices from Grin2d-/- mice, suggesting that GluN2D-containing NMDARs participate in excitatory synaptic transmission onto hippocampal interneurons. The time course of the NMDAR component of the mEPSC was unaffected by (+)-CIQ potentiation and was not accelerated in slices from Grin2d-/- mice compared with wild-type, suggesting that GluN2D does not detectably slow the NMDAR EPSC time course at this age. (+)-CIQ increased the activity of CA1 interneurons as detected by the rate and net charge transfer of spontaneous inhibitory postsynaptic currents (sIPSCs) recorded from CA1 pyramidal cells. These data provide evidence that interneurons contain synaptic NMDARs possessing a GluN2D subunit, which can influence interneuron function and signal processing.

Citing Articles

The Effects of miR-22-3p on Differentiation of Human Dental Pulp Stem Cells into Neural Progenitor-Like Cells.

Gul M, Khattak M, Qaisar R, Jayakumar M, Samsudin A, Khan A Mol Neurobiol. 2025; .

PMID: 39900772 DOI: 10.1007/s12035-025-04702-1.


NMDA Receptors in Neurodevelopmental Disorders: Pathophysiology and Disease Models.

Tumdam R, Hussein Y, Garin-Shkolnik T, Stern S Int J Mol Sci. 2024; 25(22).

PMID: 39596430 PMC: 11594297. DOI: 10.3390/ijms252212366.


Selective Enhancement of the Interneuron Network and Gamma-Band Power via GluN2C/GluN2D NMDA Receptor Potentiation.

Camp C, Banke T, Xing H, Yu K, Perszyk R, Epplin M bioRxiv. 2024; .

PMID: 39574703 PMC: 11580944. DOI: 10.1101/2024.11.05.622179.


Mechanisms of Action Underlying Conductance-Modifying Positive Allosteric Modulators of the NMDA Receptor.

Ullman E, Perszyk R, Paladugu S, Fritzemeier R, Akins N, Jacobs L Mol Pharmacol. 2024; 106(6):334-353.

PMID: 39443157 PMC: 11585258. DOI: 10.1124/molpharm.124.001019.


BNST GluN2D-containing NMDARs contribute to ethanol intake but not negative affective behaviors in female mice.

Doyle M, Salimando G, Altemus M, Badt J, Bedenbaugh M, Vardy A Alcohol Clin Exp Res (Hoboken). 2024; 48(10):1876-1891.

PMID: 39179522 PMC: 11464179. DOI: 10.1111/acer.15432.


References
1.
Hansen K, Ogden K, Yuan H, Traynelis S . Distinct functional and pharmacological properties of Triheteromeric GluN1/GluN2A/GluN2B NMDA receptors. Neuron. 2014; 81(5):1084-1096. PMC: 3957490. DOI: 10.1016/j.neuron.2014.01.035. View

2.
Hallett P, Standaert D . Rationale for and use of NMDA receptor antagonists in Parkinson's disease. Pharmacol Ther. 2004; 102(2):155-74. DOI: 10.1016/j.pharmthera.2004.04.001. View

3.
Cauli B, Audinat E, Lambolez B, Angulo M, Ropert N, Tsuzuki K . Molecular and physiological diversity of cortical nonpyramidal cells. J Neurosci. 1997; 17(10):3894-906. PMC: 6573690. View

4.
Santangelo Freel R, Ogden K, Strong K, Khatri A, Chepiga K, Jensen H . Correction to Synthesis and Structure Activity Relationship of Tetrahydroisoquinoline-Based Potentiators of GluN2C and GluN2D Containing N-Methyl-d-aspartate Receptors. J Med Chem. 2014; 57(11):4975. PMC: 4861146. DOI: 10.1021/jm500710w. View

5.
Standaert D, Landwehrmeyer G, KERNER J, Penney Jr J, Young A . Expression of NMDAR2D glutamate receptor subunit mRNA in neurochemically identified interneurons in the rat neostriatum, neocortex and hippocampus. Brain Res Mol Brain Res. 1996; 42(1):89-102. DOI: 10.1016/s0169-328x(96)00117-9. View